Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Q4 2023 Earnings Call Transcript

Fulcrum Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.4, expectations were $-0.44.

Related Keywords

,Michael Burry ,Iain Fraser ,Joseph Schwartz ,Alex Sapir ,Matthew Biegler ,Corinne Johnson ,Alan Musso ,Glaxosmithkline ,Fulcrum Therapeutics Inc ,Nasdaq ,Goldman Sachs ,Exchange Commission ,Fulcrum Therapeutics ,Call Transcript February ,Fulcrum Therapeutics Fourth Quarter ,Full Year ,Business Update Conference ,Private Security Litigation Reform Act ,Joining Alex ,Chief Financial Officer ,Interim Chief Medical ,Stock Picks ,Joori Park ,Chief Medical ,